|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
JP3507486B2
(ja)
|
1991-03-15 |
2004-03-15 |
アムジエン・インコーポレーテツド |
顆粒球コロニー刺激因子の肺内投与
|
|
US5858784A
(en)
|
1991-12-17 |
1999-01-12 |
The Regents Of The University Of California |
Expression of cloned genes in the lung by aerosol- and liposome-based delivery
|
|
US5716644A
(en)
|
1992-06-11 |
1998-02-10 |
Alkermes, Inc. |
Composition for sustained release of non-aggregated erythropoietin
|
|
US5674534A
(en)
|
1992-06-11 |
1997-10-07 |
Alkermes, Inc. |
Composition for sustained release of non-aggregated erythropoietin
|
|
US5451569A
(en)
|
1994-04-19 |
1995-09-19 |
Hong Kong University Of Science And Technology R & D Corporation Limited |
Pulmonary drug delivery system
|
|
US5989463A
(en)
|
1997-09-24 |
1999-11-23 |
Alkermes Controlled Therapeutics, Inc. |
Methods for fabricating polymer-based controlled release devices
|
|
CA2272971C
(en)
*
|
1998-10-29 |
2008-01-15 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Quinone derivatives for treating or preventing diseases associated with iron overload
|
|
US6245740B1
(en)
|
1998-12-23 |
2001-06-12 |
Amgen Inc. |
Polyol:oil suspensions for the sustained release of proteins
|
|
WO2005033093A1
(en)
|
2003-09-19 |
2005-04-14 |
Galileo Pharmaceuticals, Inc. |
7,8-bicycloalkyl-chroman derivatives
|
|
ES2619303T3
(es)
|
2005-06-01 |
2017-06-26 |
Edison Pharmaceuticals, Inc. |
Productos terapéuticos redox activos para el tratamiento de enfermedades mitocondriales y otras afecciones y modulación de biomarcadores energéticos
|
|
SI1933821T1
(sl)
|
2005-09-15 |
2020-11-30 |
Ptc Therapeutics, Inc. |
Repne variante redoks-aktivnih terapevtikov za zdravljenje mitohondrijskih bolezni in drugih bolezni ter modulacijo energijskih biooznačevalcev
|
|
EP2332534B1
(en)
|
2006-02-22 |
2018-11-14 |
Bioelectron Technology Corporation |
Phenol and benzoquinone derivatives for use in the treatment of mitochondrial diseases and modulation of energy biomarkers
|
|
WO2007100652A2
(en)
|
2006-02-22 |
2007-09-07 |
Edison Pharmaceuticals, Inc. |
Side chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
|
|
WO2009111576A2
(en)
|
2008-03-05 |
2009-09-11 |
Edison Pharmaceuticals, Inc. |
2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES
|
|
JP5798481B2
(ja)
|
2008-06-25 |
2015-10-21 |
エジソン ファーマシューティカルズ， インコーポレイテッド |
酸化ストレス疾患を治療するための２−ヘテロシクリルアミノアルキル−（ｐ−キノン）誘導体
|
|
MX363223B
(es)
|
2008-09-10 |
2019-03-15 |
Bioelectron Tech Corp |
Tratamiento de trastornos generalizados del desarrollo con terapeuticos con actividad redox.
|
|
ES2553557T3
(es)
|
2008-10-28 |
2015-12-10 |
Edison Pharmaceuticals, Inc. |
Proceso para la producción de alfa-tocotrienol y derivados
|
|
EP2246048A1
(en)
|
2009-04-30 |
2010-11-03 |
Santhera Pharmaceuticals (Schweiz) AG |
Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis
|
|
NO2470168T3
(https=)
|
2009-08-26 |
2018-06-30 |
|
|
|
SG187744A1
(en)
|
2010-08-06 |
2013-03-28 |
Edison Pharmaceuticals Inc |
Treatment of mitochondrial diseases with naphthoquinones
|
|
DK2605769T3
(en)
|
2010-08-16 |
2016-10-24 |
Santhera Pharmaceuticals (Schweiz) Ag |
Benzoquinonderivater for the treatment of mitochondrial diseases of the eye
|
|
EP2606022A2
(en)
|
2010-08-16 |
2013-06-26 |
Santhera Pharmaceuticals (Schweiz) AG |
Novel benzoquinone derivatives and use thereof as modulators of mitochondrial function
|
|
US20120295985A1
(en)
|
2010-11-19 |
2012-11-22 |
Miller Guy M |
Methods for improving blood glucose control
|
|
WO2012170773A1
(en)
|
2011-06-08 |
2012-12-13 |
Edison Pharmaceuticals, Inc. |
Adjunctive therapy for the treatment of mitochondrial disorders with quinones and naphthoquinones
|
|
KR102137450B1
(ko)
|
2012-07-12 |
2020-07-27 |
콘드리온 아이피 비.브이. |
미토콘드리아 질환을 치료하기 위한 크로마닐 유도체
|
|
CA2883882A1
(en)
|
2012-09-07 |
2014-03-13 |
Ptc Therapeutics, Inc. |
Benzoquinone derivatives for treating oxidative stress disorders
|
|
CN104870432B
(zh)
|
2012-11-16 |
2017-05-03 |
美国健康及人类服务部 |
作为溶酶体贮积症的修复剂的生育酚和生育醌衍生物
|
|
US10189830B2
(en)
|
2013-03-15 |
2019-01-29 |
Bioelectron Technology Corporation |
Alkyl-heteroaryl substituted quinone derivatives for treatment of oxidative stress disorders
|
|
WO2015183963A2
(en)
|
2014-05-28 |
2015-12-03 |
Stealth Peptides International, Inc. |
Therapeutic compositions including redox-active parabenzoquinones and uses thereof
|
|
EP3377179B1
(en)
|
2015-11-19 |
2021-04-07 |
Concert Pharmaceuticals Inc. |
Deuterated epi-743
|
|
US10703701B2
(en)
|
2015-12-17 |
2020-07-07 |
Ptc Therapeutics, Inc. |
Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
|
|
CA3011293A1
(en)
|
2016-01-12 |
2017-07-20 |
Ptc Therapeutics, Inc. |
Tocopherol and tocotrienol quinone derivatives for increasing thiosulfate levels or decreasing hydrogen sulfide levels
|
|
WO2018191732A1
(en)
*
|
2017-04-14 |
2018-10-18 |
Bioelectron Technology Corporation |
Methods and compositions for treatment of inflammation and oxidative stress
|
|
JP7266304B2
(ja)
|
2017-04-21 |
2023-04-28 |
ユニヴァーシティー オブ タスマニア |
治療化合物および方法
|
|
ES2942631T3
(es)
|
2017-12-15 |
2023-06-05 |
Stealth Biotherapeutics Inc |
Péptidos dirigidos a mitocondrias
|